Ghalamkari Safoura, Mianesaz Hamidreza, Chitsaz Ahmad, Ghazavi Mohammadreza, Salehi Mansoor
Division of Clinical Genetics, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Department of Human Genetics, Medical School, University of Debrecen, Debrecen, Hungary.
Am J Med Genet A. 2025 Apr;197(4):e63915. doi: 10.1002/ajmg.a.63915. Epub 2024 Dec 10.
Intellectual disability (ID) is a leading cause for referral to genetic services, with the most severe cases typically attributed to single genetic defects. This study aimed to evaluate the diagnostic yield of cost-effective proband-only exome sequencing for individuals diagnosed with ID within the Iranian population for the first time where a high rate of parental consanguinity exists. A total of 99 unrelated patients with ID were investigated by exome sequencing during 8 years. As a result, 43 pathogenic/likely pathogenic variants were identified in 40 patients, indicating a molecular diagnostic rate of 40.4% (40/99). The inclusion of five chromosomal copy number variations in the subsequent analysis increased the diagnostic rate of proband-only exome sequencing to 45.4% (45/99). Additionally, parental testing revealed five de novo variants. This contributed to a total diagnostic rate of 50.5% (50/99). In our study, proband-only exome sequencing achieved a remarkable diagnostic rate, identifying nearly half of the ID cases. This rate of diagnosis could be primarily attributed to prevalent consanguineous marriage in the Iranian population and the rare identification of de novo variants. With the ongoing advancements in neurogenetics, proband-only exome sequencing demonstrates significant potential as a future cost-effective diagnostic approach in Iran.
智力残疾(ID)是转诊至遗传服务机构的主要原因,最严重的病例通常归因于单一基因缺陷。本研究旨在评估仅对先证者进行的经济高效的外显子组测序在伊朗人群中对首次诊断为ID的个体的诊断率,该人群中父母近亲结婚率很高。在8年期间,共对99名无关的ID患者进行了外显子组测序调查。结果,在40名患者中鉴定出43个致病/可能致病的变异,分子诊断率为40.4%(40/99)。在后续分析中纳入5个染色体拷贝数变异后,仅对先证者进行的外显子组测序诊断率提高到45.4%(45/99)。此外,对父母的检测发现了5个新发变异。这使得总诊断率达到50.5%(50/99)。在我们的研究中,仅对先证者进行的外显子组测序实现了显著的诊断率,识别出近一半的ID病例。这一诊断率主要可归因于伊朗人群中普遍的近亲结婚以及新发变异的罕见发现。随着神经遗传学的不断进步,仅对先证者进行的外显子组测序作为伊朗未来一种经济高效的诊断方法显示出巨大潜力。